The drug industry's voice for manufacturing excellence
Production
Development
Information Technology
Compliance
Quality & Risk
Sections
Production
Development
Information Technology
Compliance
Quality & Risk
Facilities
Sectors
Special
Webinars
Podcasts
E-Handbooks
Industry News
Magazine Archives
Contact
Newsletter Subscription
Contact Us
Advertise
Follow us on
https://www.facebook.com/pages/Pharmaceutical-Manufacturing/140261116014887
http://www.linkedin.com/groups?gid=1813799
http://twitter.com/PharmaMfg
Home
Akorn Gets Warning Letter from FDA
Akorn Pharma's Decatur, Illinois plant has received a warning letter for GMP violations in the manufacture of its
IC-Green intravenous dye
.� Ouch.
pharmamanufacturing
April 2, 2007
Akorn Pharma's Decatur, Illinois plant has received a warning letter for GMP violations in the manufacture of its
IC-Green intravenous dye
.� Ouch.
About the Author
pharmamanufacturing
pharmamanufacturing
Sign up for Pharma Manufacturing Newsletters
Get the latest news and updates
SIGN UP
Related
Eli Lilly’s new Concord, North Carolina site was built with NASCAR-like speed
Celltrion to buy US biologics manufacturing plant as part of tariff response strategy
Sponsored
OnTrak Wireless: Total Bearing Health Solution
Sponsored
OnTrak Wireless & UltraTrak Vario Lubricators: Bearing Health Unified
Trending
Can CDMOs keep up with the increasing demand for GLP-1 medications?
Siegfried’s small molecule sales to drive 5.9% CAGR through 2029: analysts
Enzene opens its first US biomanufacturing site, touts continuous manufacturing capabilities
Recommended
Ultrasound Power: OnTrak Wireless Detects Bearing Faults Earlier
OnTrak Wireless & UltraTrak Vario Lubricators: Bearing Health Unified
OnTrak Wireless: Total Bearing Health Solution
Load More Content